Article ID Journal Published Year Pages File Type
5845588 Pulmonary Pharmacology & Therapeutics 2016 5 Pages PDF
Abstract
Transitioning patients from parenteral to inhaled prostacyclin therapy can be safely accomplished in specialized centers over a 48-72 h period. Patient preference was overwhelming the most prevalent reason for transition.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Preview
Transitioning from parenteral to inhaled prostacyclin therapy in pulmonary arterial hypertension
Authors
, , , ,